TSH overcomes Braf(V600E)-induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancer. (Q52664598)

http://europepmc.org/abstract/PMC/6310059

30 June 2019

title

TSH overcomes Braf(V600E)-induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancer. (English)

1 reference

http://europepmc.org/abstract/PMC/6310059

30 June 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

M Zou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

E Y Baitei

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

R A Al-Rijjal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

R S Parhar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

F A Al-Mohanna

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

S Kimura

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

H A Binessa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

A S Alzahrani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

H H Al-Khalaf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

M Akhtar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

A M Assiri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

B F Meyer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

language of work or name

English

0 references

publication date

19 October 2015

1 reference

http://europepmc.org/abstract/PMC/6310059

30 June 2019

published in

Oncogene

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

1909-1918

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

5 June 2020

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC6310059/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

cites work

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Recurrence of differentiated thyroid cancer in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

BRAF mutation in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Mutationally activated BRAF(V600E) elicits papillary thyroid cancer in the adult mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Postnatal expression of BRAFV600E does not induce thyroid cancer in mouse models of thyroid papillary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

BRAFE600-associated senescence-like cell cycle arrest of human naevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Oncogenic Braf induces melanocyte senescence and melanoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Liver resection-associated macrophage inflammatory protein-2 stimulates engraftment but not growth of colorectal metastasis at extrahepatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Many roads lead to oncogene-induced senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Oncogene-induced senescence as an initial barrier in lymphoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

A negative feedback signaling network underlies oncogene-induced senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Pten is essential for embryonic development and tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Tumour biology: senescence in premalignant tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Evidence of oncogene-induced senescence in thyroid carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

p53 family proteins in thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Pten loss in the mouse thyroid causes goiter and follicular adenomas: insights into thyroid function and Cowden disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Activating BRAF and PIK3CA mutations cooperate to promote anaplastic thyroid carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

A small molecule inhibitor for phosphatase and tensin homologue deleted on chromosome 10 (PTEN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Thyrocyte-specific expression of Cre recombinase in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Expression of endogenous oncogenic V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Increasing incidence of thyroid cancer in the United States, 1973-2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

BRAF Mutations in Papillary Thyroid Carcinomas Inhibit Genes Involved in Iodine Metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

The association between serum TSH concentration and thyroid cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

G-CSF stimulates angiogenesis and promotes tumor growth: potential contribution of bone marrow-derived endothelial progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.253

Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26477313

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/ONC.2015.253

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

PubMed publication ID

26477313

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26477313%20AND%20SRC:MED&resulttype=core&format=json